0001610717-24-000347.txt : 20240620
0001610717-24-000347.hdr.sgml : 20240620
20240620161050
ACCESSION NUMBER: 0001610717-24-000347
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240617
FILED AS OF DATE: 20240620
DATE AS OF CHANGE: 20240620
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wei Lin
CENTRAL INDEX KEY: 0001872772
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39219
FILM NUMBER: 241056324
MAIL ADDRESS:
STREET 1: C/O ERASCA, INC.
STREET 2: 10835 ROAD TO THE CURE, SUITE 140
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Revolution Medicines, Inc.
CENTRAL INDEX KEY: 0001628171
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 472029180
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 700 SAGINAW DR
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
BUSINESS PHONE: 415-766-3638
MAIL ADDRESS:
STREET 1: 700 SAGINAW DR
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
4
1
form4.xml
X0508
4
2024-06-17
0001628171
Revolution Medicines, Inc.
RVMD
0001872772
Wei Lin
C/O REVOLUTION MEDICINES, INC.
700 SAGINAW DRIVE
REDWOOD CITY
CA
94063
true
Chief Medical Officer
false
Common Stock
2024-06-17
4
S
0
5589
37.3867
D
70851
D
Pursuant to an automatic sell-to-cover imposed by the terms of the restricted stock units ("RSUs") award, the shares were sold following the vesting of the RSUs solely to cover applicable withholding taxes.
This transaction was executed in multiple trades in prices ranging from $37.3867 to $37.3871, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
Includes 2,040 shares acquired under the Issuer's Employee Stock Purchase Plan on May 31, 2024.
Includes 59,250 RSUs.
/s/ Jack Anders, as Attorney-in-fact for Wei Lin
2024-06-20